[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hormone Replacement Therapeutics Market Research Report 2023

December 2023 | 97 pages | ID: GB1AB91116A6EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Hormone replacement drugs refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.

According to QYResearch’s new survey, global Hormone Replacement Therapeutics market is projected to reach US$ 18490 million in 2029, increasing from US$ 1662 million in 2022, with the CAGR of 1.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hormone Replacement Therapeutics market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hormone Replacement Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Eli Lilly
  • Pfizer
  • AbbVie
  • Novo Nordisk
  • Merck KGaA
  • Viatris
  • Bayer
  • Teva
  • Novartis
  • Abbott
  • Roche
  • Endo International
  • Ipsen
  • ANI Pharmaceuticals
  • TherapeuticsMD
Segment by Type
  • Estrogen Hormone
  • Growth Hormone
  • Thyroid Hormone
  • Testosterone Hormone
Segment by Application
  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Male Hypogonadism
  • Other Diseases
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Hormone Replacement Therapeutics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Hormone Replacement Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Estrogen Hormone
  1.2.3 Growth Hormone
  1.2.4 Thyroid Hormone
  1.2.5 Testosterone Hormone
1.3 Market by Application
  1.3.1 Global Hormone Replacement Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Menopause
  1.3.3 Hypothyroidism
  1.3.4 Growth Hormone Deficiency
  1.3.5 Male Hypogonadism
  1.3.6 Other Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Hormone Replacement Therapeutics Market Perspective (2018-2029)
2.2 Hormone Replacement Therapeutics Growth Trends by Region
  2.2.1 Global Hormone Replacement Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Hormone Replacement Therapeutics Historic Market Size by Region (2018-2023)
  2.2.3 Hormone Replacement Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Hormone Replacement Therapeutics Market Dynamics
  2.3.1 Hormone Replacement Therapeutics Industry Trends
  2.3.2 Hormone Replacement Therapeutics Market Drivers
  2.3.3 Hormone Replacement Therapeutics Market Challenges
  2.3.4 Hormone Replacement Therapeutics Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hormone Replacement Therapeutics Players by Revenue
  3.1.1 Global Top Hormone Replacement Therapeutics Players by Revenue (2018-2023)
  3.1.2 Global Hormone Replacement Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Hormone Replacement Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hormone Replacement Therapeutics Revenue
3.4 Global Hormone Replacement Therapeutics Market Concentration Ratio
  3.4.1 Global Hormone Replacement Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Hormone Replacement Therapeutics Revenue in 2022
3.5 Hormone Replacement Therapeutics Key Players Head office and Area Served
3.6 Key Players Hormone Replacement Therapeutics Product Solution and Service
3.7 Date of Enter into Hormone Replacement Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HORMONE REPLACEMENT THERAPEUTICS BREAKDOWN DATA BY TYPE

4.1 Global Hormone Replacement Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Hormone Replacement Therapeutics Forecasted Market Size by Type (2024-2029)

5 HORMONE REPLACEMENT THERAPEUTICS BREAKDOWN DATA BY APPLICATION

5.1 Global Hormone Replacement Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Hormone Replacement Therapeutics Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Hormone Replacement Therapeutics Market Size (2018-2029)
6.2 North America Hormone Replacement Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hormone Replacement Therapeutics Market Size by Country (2018-2023)
6.4 North America Hormone Replacement Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Hormone Replacement Therapeutics Market Size (2018-2029)
7.2 Europe Hormone Replacement Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hormone Replacement Therapeutics Market Size by Country (2018-2023)
7.4 Europe Hormone Replacement Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Hormone Replacement Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific Hormone Replacement Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hormone Replacement Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Hormone Replacement Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Hormone Replacement Therapeutics Market Size (2018-2029)
9.2 Latin America Hormone Replacement Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hormone Replacement Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Hormone Replacement Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Hormone Replacement Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa Hormone Replacement Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hormone Replacement Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Hormone Replacement Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Detail
  11.1.2 Eli Lilly Business Overview
  11.1.3 Eli Lilly Hormone Replacement Therapeutics Introduction
  11.1.4 Eli Lilly Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.1.5 Eli Lilly Recent Development
11.2 Pfizer
  11.2.1 Pfizer Company Detail
  11.2.2 Pfizer Business Overview
  11.2.3 Pfizer Hormone Replacement Therapeutics Introduction
  11.2.4 Pfizer Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.2.5 Pfizer Recent Development
11.3 AbbVie
  11.3.1 AbbVie Company Detail
  11.3.2 AbbVie Business Overview
  11.3.3 AbbVie Hormone Replacement Therapeutics Introduction
  11.3.4 AbbVie Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
  11.4.1 Novo Nordisk Company Detail
  11.4.2 Novo Nordisk Business Overview
  11.4.3 Novo Nordisk Hormone Replacement Therapeutics Introduction
  11.4.4 Novo Nordisk Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
  11.5.1 Merck KGaA Company Detail
  11.5.2 Merck KGaA Business Overview
  11.5.3 Merck KGaA Hormone Replacement Therapeutics Introduction
  11.5.4 Merck KGaA Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.5.5 Merck KGaA Recent Development
11.6 Viatris
  11.6.1 Viatris Company Detail
  11.6.2 Viatris Business Overview
  11.6.3 Viatris Hormone Replacement Therapeutics Introduction
  11.6.4 Viatris Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.6.5 Viatris Recent Development
11.7 Bayer
  11.7.1 Bayer Company Detail
  11.7.2 Bayer Business Overview
  11.7.3 Bayer Hormone Replacement Therapeutics Introduction
  11.7.4 Bayer Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.7.5 Bayer Recent Development
11.8 Teva
  11.8.1 Teva Company Detail
  11.8.2 Teva Business Overview
  11.8.3 Teva Hormone Replacement Therapeutics Introduction
  11.8.4 Teva Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.8.5 Teva Recent Development
11.9 Novartis
  11.9.1 Novartis Company Detail
  11.9.2 Novartis Business Overview
  11.9.3 Novartis Hormone Replacement Therapeutics Introduction
  11.9.4 Novartis Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.9.5 Novartis Recent Development
11.10 Abbott
  11.10.1 Abbott Company Detail
  11.10.2 Abbott Business Overview
  11.10.3 Abbott Hormone Replacement Therapeutics Introduction
  11.10.4 Abbott Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.10.5 Abbott Recent Development
11.11 Roche
  11.11.1 Roche Company Detail
  11.11.2 Roche Business Overview
  11.11.3 Roche Hormone Replacement Therapeutics Introduction
  11.11.4 Roche Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.11.5 Roche Recent Development
11.12 Endo International
  11.12.1 Endo International Company Detail
  11.12.2 Endo International Business Overview
  11.12.3 Endo International Hormone Replacement Therapeutics Introduction
  11.12.4 Endo International Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.12.5 Endo International Recent Development
11.13 Ipsen
  11.13.1 Ipsen Company Detail
  11.13.2 Ipsen Business Overview
  11.13.3 Ipsen Hormone Replacement Therapeutics Introduction
  11.13.4 Ipsen Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
  11.14.1 ANI Pharmaceuticals Company Detail
  11.14.2 ANI Pharmaceuticals Business Overview
  11.14.3 ANI Pharmaceuticals Hormone Replacement Therapeutics Introduction
  11.14.4 ANI Pharmaceuticals Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
  11.15.1 TherapeuticsMD Company Detail
  11.15.2 TherapeuticsMD Business Overview
  11.15.3 TherapeuticsMD Hormone Replacement Therapeutics Introduction
  11.15.4 TherapeuticsMD Revenue in Hormone Replacement Therapeutics Business (2018-2023)
  11.15.5 TherapeuticsMD Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Hormone Replacement Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Estrogen Hormone
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Thyroid Hormone
Table 5. Key Players of Testosterone Hormone
Table 6. Global Hormone Replacement Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Hormone Replacement Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hormone Replacement Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Hormone Replacement Therapeutics Market Share by Region (2018-2023)
Table 10. Global Hormone Replacement Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Hormone Replacement Therapeutics Market Share by Region (2024-2029)
Table 12. Hormone Replacement Therapeutics Market Trends
Table 13. Hormone Replacement Therapeutics Market Drivers
Table 14. Hormone Replacement Therapeutics Market Challenges
Table 15. Hormone Replacement Therapeutics Market Restraints
Table 16. Global Hormone Replacement Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Hormone Replacement Therapeutics Market Share by Players (2018-2023)
Table 18. Global Top Hormone Replacement Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Replacement Therapeutics as of 2022)
Table 19. Ranking of Global Top Hormone Replacement Therapeutics Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Hormone Replacement Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hormone Replacement Therapeutics Product Solution and Service
Table 23. Date of Enter into Hormone Replacement Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hormone Replacement Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Hormone Replacement Therapeutics Revenue Market Share by Type (2018-2023)
Table 27. Global Hormone Replacement Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Hormone Replacement Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global Hormone Replacement Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Hormone Replacement Therapeutics Revenue Market Share by Application (2018-2023)
Table 31. Global Hormone Replacement Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Hormone Replacement Therapeutics Revenue Market Share by Application (2024-2029)
Table 33. North America Hormone Replacement Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Hormone Replacement Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Hormone Replacement Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Hormone Replacement Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Hormone Replacement Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Hormone Replacement Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Hormone Replacement Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Hormone Replacement Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Hormone Replacement Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Hormone Replacement Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Hormone Replacement Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hormone Replacement Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Hormone Replacement Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Hormone Replacement Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Hormone Replacement Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 48. Eli Lilly Company Detail
Table 49. Eli Lilly Business Overview
Table 50. Eli Lilly Hormone Replacement Therapeutics Product
Table 51. Eli Lilly Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 52. Eli Lilly Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Hormone Replacement Therapeutics Product
Table 56. Pfizer Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. AbbVie Company Detail
Table 59. AbbVie Business Overview
Table 60. AbbVie Hormone Replacement Therapeutics Product
Table 61. AbbVie Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 62. AbbVie Recent Development
Table 63. Novo Nordisk Company Detail
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Hormone Replacement Therapeutics Product
Table 66. Novo Nordisk Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 67. Novo Nordisk Recent Development
Table 68. Merck KGaA Company Detail
Table 69. Merck KGaA Business Overview
Table 70. Merck KGaA Hormone Replacement Therapeutics Product
Table 71. Merck KGaA Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 72. Merck KGaA Recent Development
Table 73. Viatris Company Detail
Table 74. Viatris Business Overview
Table 75. Viatris Hormone Replacement Therapeutics Product
Table 76. Viatris Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 77. Viatris Recent Development
Table 78. Bayer Company Detail
Table 79. Bayer Business Overview
Table 80. Bayer Hormone Replacement Therapeutics Product
Table 81. Bayer Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Teva Company Detail
Table 84. Teva Business Overview
Table 85. Teva Hormone Replacement Therapeutics Product
Table 86. Teva Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 87. Teva Recent Development
Table 88. Novartis Company Detail
Table 89. Novartis Business Overview
Table 90. Novartis Hormone Replacement Therapeutics Product
Table 91. Novartis Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Abbott Company Detail
Table 94. Abbott Business Overview
Table 95. Abbott Hormone Replacement Therapeutics Product
Table 96. Abbott Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Roche Company Detail
Table 99. Roche Business Overview
Table 100. Roche Hormone Replacement Therapeutics Product
Table 101. Roche Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 102. Roche Recent Development
Table 103. Endo International Company Detail
Table 104. Endo International Business Overview
Table 105. Endo International Hormone Replacement Therapeutics Product
Table 106. Endo International Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 107. Endo International Recent Development
Table 108. Ipsen Company Detail
Table 109. Ipsen Business Overview
Table 110. Ipsen Hormone Replacement Therapeutics Product
Table 111. Ipsen Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 112. Ipsen Recent Development
Table 113. ANI Pharmaceuticals Company Detail
Table 114. ANI Pharmaceuticals Business Overview
Table 115. ANI Pharmaceuticals Hormone Replacement Therapeutics Product
Table 116. ANI Pharmaceuticals Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 117. ANI Pharmaceuticals Recent Development
Table 118. TherapeuticsMD Company Detail
Table 119. TherapeuticsMD Business Overview
Table 120. TherapeuticsMD Hormone Replacement Therapeutics Product
Table 121. TherapeuticsMD Revenue in Hormone Replacement Therapeutics Business (2018-2023) & (US$ Million)
Table 122. TherapeuticsMD Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Hormone Replacement Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Hormone Replacement Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Estrogen Hormone Features
Figure 4. Growth Hormone Features
Figure 5. Thyroid Hormone Features
Figure 6. Testosterone Hormone Features
Figure 7. Global Hormone Replacement Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Hormone Replacement Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Menopause Case Studies
Figure 10. Hypothyroidism Case Studies
Figure 11. Growth Hormone Deficiency Case Studies
Figure 12. Male Hypogonadism Case Studies
Figure 13. Other Diseases Case Studies
Figure 14. Hormone Replacement Therapeutics Report Years Considered
Figure 15. Global Hormone Replacement Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Hormone Replacement Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Hormone Replacement Therapeutics Market Share by Region: 2022 VS 2029
Figure 18. Global Hormone Replacement Therapeutics Market Share by Players in 2022
Figure 19. Global Top Hormone Replacement Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Replacement Therapeutics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Hormone Replacement Therapeutics Revenue in 2022
Figure 21. North America Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Hormone Replacement Therapeutics Market Share by Country (2018-2029)
Figure 23. United States Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Hormone Replacement Therapeutics Market Share by Country (2018-2029)
Figure 27. Germany Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Hormone Replacement Therapeutics Market Share by Region (2018-2029)
Figure 35. China Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Hormone Replacement Therapeutics Market Share by Country (2018-2029)
Figure 43. Mexico Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Hormone Replacement Therapeutics Market Share by Country (2018-2029)
Figure 47. Turkey Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Hormone Replacement Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Eli Lilly Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 51. AbbVie Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 52. Novo Nordisk Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 53. Merck KGaA Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 54. Viatris Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 55. Bayer Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 56. Teva Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 59. Roche Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 60. Endo International Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 61. Ipsen Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 62. ANI Pharmaceuticals Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 63. TherapeuticsMD Revenue Growth Rate in Hormone Replacement Therapeutics Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


More Publications